浏览全部资源
扫码关注微信
1.广东省妇幼保健院成人重症监护室,广州 511442
2.广州中医药大学中药学院,广州 510006
3.东莞广州中医药大学研究院,广东 东莞 523808
主治医师,硕士。研究方向:妊娠合并内科疾病、妊娠急危重症。E-mail:290642013@qq.com
助理研究员,博士。研究方向:中药新药研究及药物制剂新技术。E-mail:linrongfeng@gzucm.edu.cn
纸质出版日期:2023-09-15,
收稿日期:2023-04-06,
修回日期:2023-06-20,
扫 描 看 全 文
钟旋,李袁袁,林荣锋等.大承气汤对肠源性脓毒症小鼠的保护作用及机制 Δ[J].中国药房,2023,34(17):2101-2106.
ZHONG Xuan,LI Yuanyuan,LIN Rongfeng,et al.Protective effects and mechanism of Dachengqi decoction on intestinal septic mice[J].ZHONGGUO YAOFANG,2023,34(17):2101-2106.
钟旋,李袁袁,林荣锋等.大承气汤对肠源性脓毒症小鼠的保护作用及机制 Δ[J].中国药房,2023,34(17):2101-2106. DOI: 10.6039/j.issn.1001-0408.2023.17.10.
ZHONG Xuan,LI Yuanyuan,LIN Rongfeng,et al.Protective effects and mechanism of Dachengqi decoction on intestinal septic mice[J].ZHONGGUO YAOFANG,2023,34(17):2101-2106. DOI: 10.6039/j.issn.1001-0408.2023.17.10.
目的
2
研究大承气汤(DCQD)对肠源性脓毒症小鼠的保护作用,并从Toll样受体4/髓分化因子88(TLR4/MyD88)信号通路探讨其可能机制。
方法
2
将SPF级雄性C57BL/6J小鼠分为假手术(Sham)组、假手术+大承气汤高剂量(Sham+DCQD-H)组、模型(CLP)组、大承气汤低剂量(DCQD-L)组、大承气汤高剂量(DCQD-H)组、阳性对照(Positive)组。CLP组、DCQD-L组、DCQD-H组和Positive组小鼠均以盲肠结扎穿刺法建立肠源性脓毒症模型;DCQD-L组和DCQD-H组小鼠在术前3 d和术后7 d每天分别按4、8 g/kg(按生药量计)灌胃给予大承气汤;Positive组在术前2 h腹腔注射乌司他丁1次,术后7 d每天腹腔注射乌司他丁1次,剂量均为50 000 U/kg。Sham组和Sham+DCQD-H组仅暴露盲肠,不做结扎及穿刺;Sham+DCQD-H组在术前3 d和术后7 d每天灌胃给予大承气汤(8 g/kg,按生药量计);Sham组和CLP组每天均灌胃和腹腔注射生理盐水各0.2 mL,连续10 d。术后7 d每天评估小鼠脓毒症严重程度,并评估小鼠7 d生存率;末次给药1 h后,检测小鼠血清和回肠组织中肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)水平;观察小鼠肝、肺、肾、回肠组织的病理学形态变化;检测小鼠回肠组织中TLR4、MyD88 mRNA表达水平。
结果
2
与CLP组比较,DCQD-L组、DCQD-H组小鼠脓毒症评分,血清和回肠组织中TNF-α、IL-6水平(DCQD-L组回肠组织中IL-6除外),肝、肺、肾、回肠组织损伤评分,回肠组织中TLR4、MyD88 mRNA表达水平均显著降低(
P
<0.05或
P
<0.01);7 d生存率(DCQD-L组除外)显著升高(
P
<0.05);小鼠肝细胞组织损伤明显改善,炎症浸润和凋亡减少;肺组织损伤有所缓解,肺泡萎缩、出血、水肿均有不同程度的改善;肾组织损伤改善,肾小管管腔扩张减弱;回肠组织损伤及水肿均有明显改善。
结论
2
大承气汤对肠源性脓毒症模型小鼠具有保护作用,其作用机制可能与抑制全身炎症、减轻多器官损伤以及下调TLR4/MyD88信号通路有关。
OBJECTIVE
2
To study the protective effects of Dachengqi decoction (DCQD) on intestinal septic mice, and to explore the possible mechanisms from the Toll-like receptor 4(TLR4)/myeloid differentiation factor 88(MyD88) signaling pathway.
METHODS
2
The SPF male C57BL/6J mice were randomly divided into Sham group, Sham+DCQD-H group, model (CLP) group, DCQD-L group, DCQD-H group and Positive group. The model of intestinal sepsis was established by cecal ligation and puncture in CLP group, DCQD-L group, DCQD-H group and Positive group. Three days before the operation and seven days after the operation, DCQD-L group and DCQD-H group were given DCQD intragastrically at 4, 8 g/kg (calculated by crude drug), respectively. Positive group was given ulinastatin intraperitoneally 2 h before operation and 7 d after the operation (at 50 000 U/kg). In Sham group and Sham+DCQD-H group, only cecum of mice was exposed without ligation and puncture. Sham+DCQD-H group was given DCQD intragastrically (8 g/kg,calculated by crude drug) 3 days before the operation and 7 days after the operation. Both the Sham group and CLP group were given normal saline 0.2 mL intragstrically and intraperitoneally each day, for 10 consecutive days. After the operation, the severity of sepsis was assessed, and the 7 d survival rate of mice was assessed. One hour after the last medication, the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in serum and ileum of mice were determined; the pathological and morphological changes of mice’s liver, lung, kidney and ileum were observed; mRNA expressions of the TLR4 and MyD88 in ileum were tested.
RESULTS
2
Compared with CLP group, sepsis score, the levels of TNF-α and IL-6 in serum and ileum (except for IL-6 in ileum of DCQD-L group), damage score of the liver, lung, kidney and ileum, mRNA expressions of TLR4 and MyD88 in ileum were all decreased significantly in DCQD-L group and DCQD-H group (
P
<0.05 or
P
<0.01), while 7 d survival rate (except for DCQD-L group) was increased significantly (
P
<0.05). The damage to liver tissue in mice was significantly improved, and inflammation infiltration and apoptosis were reduced; lung tissue damage had been alleviated, with varying degrees of improvement in alveolar atrophy, bleeding and edema; the renal tissue damage was improved and weakened dilation of renal tubular lumen was weakened; the damage and edema of ileal tissue were significantly improved.
CONCLUSIONS
2
DCQD may exert a protective role on intestinal septic model mice. The mechanism may be related to the inhibition of systemic inflammation, the reduction of multiple organ damage, and down-regulation of TLR4/MyD88 signaling pathway.
大承气汤脓毒症炎症因子器官损伤Toll样受体4/髓分化因子88信号通路
sepsisinflammatory factororgan damageTLR4/MyD88 signaling pathway
蒲昆鹏,刘辉,张贺,等. PiCCO监测下液体复苏治疗脓毒症休克合并重度急性呼吸窘迫综合征的价值研究[J]. 中国现代医学杂志,2023,33(1):71-75.
RUDD K E,JOHNSON S C,AGESA K M,et al. Global,regional,and national sepsis incidence and mortality,1990-2017:analysis for the Global Burden of Disease Study[J]. Lancet,2020,395(10219):200-211.
GAVELLI F,CASTELLO L M,AVANZI G C. Management of sepsis and septic shock in the emergency department[J]. Intern Emerg Med,2021,16(6):1649-1661.
王仲,魏捷,朱华栋,等. 中国脓毒症早期预防与阻断急诊专家共识[J]. 中国急救医学,2020,40(7):577-588.
李岩,唐婷婷,耿艳. 大承气汤联合基础治疗对脓毒症肺损伤患者炎症指标和预后的影响[J]. 中国中医急症,2022,31(3):443-446.
陈敏,王倩. 大承气汤联合西医常规治疗干预脓毒症伴急性胃肠损伤的临床研究[J]. 上海中医药大学学报,2022,36(增刊1):20-22,102.
孙文杰,陈亚峰,李红昌,等. 大承气汤干预重症急性胰腺炎并发肝损伤的作用机制[J]. 中成药,2020,42(1):200-203.
ZHANG Y M,ZHU L,ZHAO X L,et al. Optimal timing for the oral administration of Da-Cheng-Qi Decoction based on the pharmacokinetic and pharmacodynamic targeting of the pancreas in rats with acute pancreatitis[J]. World J Gastroenterol,2017,23(39):7098-7109.
ZHANG Y S,LIANG X J,BAO X F,et al. Toll-like receptor 4 (TLR4) inhibitors:current research and prospective[J]. Eur J Med Chem,2022,235:114291.
郑静茹,季春莲,占靓卉,等. 基于网络药理学与实验验证探讨三叶青治疗脓毒症的作用及机制[J]. 中国中药杂志,2022,47(17):4744-4754.
HU Q Y,REN H J,LI G W,et al. STING-mediated intestinal barrier dysfunction contributes to lethal sepsis[J]. EBioMedicine,2019,41:497-508.
付智慧,赵灵灵,周霖,等. 基于网络药理学探讨大承气汤治疗脓毒症的作用机制及关键靶点通路验证[J]. 中国中药杂志,2021,46(20):5351-5361.
穆盛田,唐洁,仲宇,等. 乌司他丁对脂多糖诱导小鼠急性肾损伤的保护作用及其机制[J]. 中国医科大学学报,2021,50(4):336-340,355.
KARBIAN N,ABUTBUL A,EL-AMORE R,et al. Apoptotic cell therapy for cytokine storm associated with acute severe sepsis[J]. Cell Death Dis,2020,11(7):535.
SHRUM B,ANANTHA R V,XU S X,et al. A robust scoring system to evaluate sepsis severity in an animal model[J]. BMC Res Notes,2014,7:233.
梁焕宝,罗嘉慧. 丙泊酚对体外循环大鼠Nrf2/HO-1通路及肠屏障损伤的影响[J]. 中国老年学杂志,2023,43(11):2775-2780.
杨景喻,王锐,金涛,等. 基于网络药理学探讨大承气汤治疗急性胰腺炎的物质基础和分子机制[J]. 中国中药杂志,2020,45(6):1423-1432.
宋隽,黄伟,黄铭,等. 脓毒症合并多器官功能障碍患者血清中miR-155的表达及其临床意义[J]. 中华医院感染学杂志,2020,30(9):1315-1318.
郭宁珂,佘汉,谭磊,等. 小白菊内酯对脓毒症大鼠肠屏障功能的保护作用[J]. 陆军军医大学学报,2022,44(20):2068-2074.
张洁慧,肖铁刚,阙任烨,等. 大承气汤治疗胃肠功能障碍的临床及作用机制研究进展[J]. 中国中西医结合消化杂志,2019,27(1):72-76.
李君仪,竹林,向瑾,等. 大承气汤主要成分在急性胰腺炎大鼠的组织分布特征[J]. 中国实验方剂学杂志,2016,22(1):82-87.
KUZMICH N N,SIVAK K V,CHUBAREV V N,et al. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis[J]. Vaccines,2017,5(4):34.
LUO M H,LUO S X,CHENG Z,et al. Tubeimoside Ⅰ improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression[J]. Biomedecine Pharmacother,2020,126:110083.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构